Skip to main content

Study M070

Study name

Zhang W 2015

Title

A novel urinary metabolite signature for non-invasive post-stroke depression diagnosis

Overall design

Here, a GC-MS-based urinary metabolomics approach was used to characterize the urinary metabolic profiling of post-stroke depression (PSD) subjects and non-PSD subjects (HC, health controls) in order to identify and validate urinary metabolite biomarkers for PSD. 130 PSD subjects and 128 stroke subjects were recruited. The training set, including 74 HC, 72 stroke, and 72 PSD subjects, was used to identify potential urinary biomarkers. Differential urinary metabolites responsible for discriminating PSD subjects (depressed group, n = 72) from non-PSD subjects (non-depressed group, n = 146) were identified in the training sets. The training set, including 74 HC, 72 stroke, and 72 PSD subjects, was used to identify potential urinary biomarkers.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Post-stroke depression; Post-stroke depression;

Criteria for depression

DSM-IV diagnosed MDD, HAMD-17 > 8

Sample size

385

Tissue

Peripheral; Urine; Urine;

Platform

MS-based; GC-MS: not reported;

PMID

27352185

DOI

10.1007/s12013-014-0472-9

Citation

Zhang W, Zhang XA. A novel urinary metabolite signature for non-invasive post-stroke depression diagnosis. Cell Biochem Biophys 2015;72(3):661-7.

Metabolite

Glyceric acid;

Pyroglutamic acid;

Palmitic acid;

L-Phenylalanine;

L-Leucine;

L-Lactic acid;

Hippuric acid;

L-Tyrosine;

Azelaic acid;

Pseudouridine;

Indoxyl sulfate;

Hypoxanthine;

D-Ribose;

Sucrose;

3-Aminoisobutanoic acid;

5-Hydroxyhexanoic acid;

(S)-3-Hydroxyisobutyric acid;